Very late relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation.
Allogeneic stem cell transplantation is considered to be a curative treatment modality in patients with chronic myelogenous leukemia. However patients are at risk for relapse years after transplantation. Currently we present two patients who relapsed 16 and 24 years after allogeneic bone marrow transplantation, respectively. These patients emphasize the need for long term follow-up of such patients.
Department of Medicine, New York Medical College, Valhalla, NY 10595, USA.
Arunabh
A
Sekhri
Delong
D
Liu
Muhammad
M
Rasul
Nasir
N
Ahmed
Tauseef
T
Ahmed
Karen
K
Seiter
D000328:Adult; D016026:Bone Marrow Transplantation; D005260:Female; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000473:pathology / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D014184:Transplantation, Homologous